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Abstract: Chromosomal duplications are associated with a large group of human diseases that
arise mainly from dosage imbalance of genes within the rearrangements. Phenotypes range widely
but are often associated with global development delay, intellectual disability, autism spectrum
disorders, and multiple congenital abnormalities. How different contiguous genes from a duplicated
genomic region interact and dynamically affect the expression of each other remains unclear in
most cases. Here, we report a genomic comparative delineation of genes located in duplicated
chromosomal regions 8q24.13q24.3, 18p11.32p11.21, and Xq22.3q27.2 in three patients followed up at
our genetics service who has the intellectual disability (ID) as a common phenotype. We integrated
several genomic data levels by identification of gene content within the duplications, protein-protein
interactions, and functional analysis on specific tissues. We found functional relationships among
genes from three different duplicated chromosomal regions, reflecting interactions of protein-coding
genes and their involvement in common cellular subnetworks. Furthermore, the sharing of common
significant biological processes associated with ID has been demonstrated between proteins from
the different chromosomal regions. Finally, we elaborated a shared model of pathways directly or
indirectly related to the central nervous system (CNS), which could perturb cognitive function and
lead to ID in the three duplication conditions.
Keywords: duplication syndromes; intellectual disability; axon guidance; PPI-network
1. Introduction
Chromosomal duplication syndromes are caused by intrachromosomal rearrange-
ments (due to genomic instability) and may result in overexpression of dosage-sensitive
genes within the rearrangement and gene interruption or gene fusion at the breakpoint
junctions [1,2]. As a consequence, chromosomal duplications can affect multiple functional
proteins that need to be effective in terms of quantity, location, and time of activity. The
consequence of these alterations can lead to damage in brain development and/or cognitive
functioning [3,4]. Moreover, imbalances of proteins that compose multiprotein complexes
may be extremely deleterious, when stochiometric changes in subunits affect biological
processes [2,5]. Finally, the perturbation of hub-genes may also alter the expression and
function of other sets of proteins, or even, produce aggregation of proteins that lead to
cellular toxicity [2,6].
Chromosomal duplications have a prevalence of ~0.7/10.000 births and are commonly
associated with syndromic forms of Intellectual Disability (ID), a heterogeneous condition
with a worldwide prevalence of 1% [4,7] that impairs intellectual functioning and adaptive
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behavior, manifesting before adulthood [8]. Usually, duplication syndromes are identified
by Chromosomal Microarray Analysis (CMA), considered as the first-tier test that offers
15–20% of diagnostic rate for individuals with unexplained global developmental delay/ID
and/or congenital anomalies [9].
Neurological processes are tightly regulated during the development and throughout
the individual’s life in a manner that any change can have deleterious effects on cognitive
function [10]. Many cellular processes are affected in ID, including neurogenesis, neuronal
migration to axon guidance, synaptic plasticity, dendritic arborization, and regulation of
transcription and translation. These bioprocesses can converge on similar and connected
pathways, involving common phenotypic manifestations [4,10,11]. Pathophysiology caus-
ing ID comprises proteins that emerge in pathways and cellular networks involving several
biological functions that occur through interactions represented by the human interac-
tome [4,12]. Moreover, chromosomal rearrangements may include regions significantly
enriched for genes involved in brain development that can generate multiple pathogenic
mechanisms [2].
Herein we determined whether genes located in duplicated regions in three pa-
tients followed up at our genetics service with rare but relevant regions (8q24.13q24.3,
18p11.32p11.21, and Xq22.3q27.2) are involved in shared central molecular pathways as-
sociated with genes related with ID. The 8q24.13q24.3 duplication identified is a rare
chromosomal rearrangement associated with dysmorphic features, growth delay, and
ID [13–16]. Moreover, variable levels of ID and cerebellum hypoplasia were described in
patients with 18p11 duplications, however, few cases of pure duplications in this region
have been reported with similar rearrangements so far [17–21]. Duplication at Xq22.3q27.2
is a condition with region enriched in genes related to neurological function involving
many cases of ID, behavioral problems, holoprosencephaly, and cerebellar vermis hy-
poplasia [22–26]. Therefore, we integrated several levels of data by identification of gene
content, protein-protein interactions, and functional analysis on specific tissues to suggest
a model with common or related pathways to the central nervous system (CNS) functions
in individuals affected by these duplication syndromes.
2. Materials and Methods
2.1. Chromosomal Microarray Analysis (CMA)
Three patients with ID were followed in the Medical Genetics Service—HCPA. The
duplications were mapped by CMA using a 60-mer oligonucleotide-based microarray with
a theoretical resolution of 40 kb (8 × 60 K, Agilent Technologies Inc., Santa Clara, CA,
USA). The labeling and hybridization were performed following the protocols provided
by Agilent, 2011. The arrays were analyzed using a microarray scanner (G2600D) and the
Feature Extraction software (version 9.5.1, both from Agilent Technologies). UCSC Genome
Browser on Human Feb. 2009 (GRCh37/hg19) was employed to identify all protein-coding
genes from duplicated regions. The complete list of protein-coding genes can be seen in
Supplementary Table S1.
2.2. Interactome Construction and the Expanded Duplication Syndromes Interactome (eDSi)
The human interactome was generated using the Human Integrated Protein-Protein
Interaction Reference (HIPPIE) database (version 2.2) [27]. We filtered in the interactions
with confidence score > 0.4 and limited our analysis to the largest connected component,
containing 16,108 nodes and 256,552 links/edges. Next, we extracted only protein-protein
interactions from the three selected duplicated regions (Supplementary Table S2) and se-
lected their first neighbor to expand and generate the eDSi. Cytoscape V.3.7.0. software [28]
was used for visualization, and calculations of centrality parameters of the networks.
2.3. Functional Modules Detection and Enrichment Analysis
The HumanBase database integrates functional networks in tissues, gene expression, and
disease associations. Evidence is provided by a massive set of experiments containing more
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than 14,000 publications and 144 tissue- and cell lineage-specific functional contexts [29,30].
We extracted significant biological processes in the eDSi, by using the detection of functional
modules tool in specific tissues available in the HumanBase [31]. This tool allows the de-
tection of tissue-specific functional modules, comprising related genes located in clusters
that share local network neighborhood. The method uses k-nearest-neighbor (SKNN) and
the Louvain community-finding algorithm to cluster the genes list into distinct modules
of tightly connected genes [31]. q value was calculated using one-sided Fisher’s exact tests
and Benjamini–Hochberg corrections to correct for multiple tests and only values < 0.05
were considered (Supplementary Table S3). Moreover, we used the webserver Enrichr [32]
to identify significant pathways involved with neuronal functions in genes from the tissue-
specific network. The gene-set libraries used were BioCarta, BioPlanet, Elsevier Pathway
Collection, Kegg, Reactome, Panther, and WikiPathways. We considered only bioprocesses
with a p-value < 0.05.
2.4. Prioritization of Candidate Genes
To prioritize candidate genes associated with ID, we used a list of known ID-genes
(Supplementary Table S4), available at http://www.disgenet.org/ (accessed on 6 January
2020). DisGeNET is a platform that integrates data from UNIPROT, CGI, ClinGen, Ge-
nomics England, CTD (human subset), PsyGeNET, and Orphanet on human gene-disease
associations [33]. We used a query list of ID-genes to expand the selection of nodes, using
network propagation through the Diffusion algorithm (V. 1.6.1) [34]. Network propagation
can estimate the distance between different sets of proteins, and identify a subnetwork
with nodes closely related to each other [34]. The proximity among candidate genes and
query ID-genes in the eDSi was measured using 302 as a maximum diffusion rank (highest
allowed value). The complete list of prioritized genes is shown in Supplementary Table S5.
2.5. Functional Tissue-Specific Data
We used the list of the prioritized genes (Supplementary Table S5) to identify gene
expression in tissues and construct a gene-disease association network in the Human-
Base [29,30]. Moreover, a tissue-specific network with 18 genes highly expressed in the
CNS was generated using data from co-expression, protein interaction, TF binding, mi-
croRNA targets, and perturbations. We prioritized the most expressed genes in the CNS,
or genes previously reported in the literature involving ID in individuals with duplication
regions. The parameters used to generate the network were a confidence >0.10 and a value
of 15 for the maximum number of genes.
3. Results
3.1. Identification of Rare Chromosome Duplications
Chromosome duplications were mapped using the samples of three patients with ID
using hg/19 reference: 8q24.13q24.3 (Chr8:126,397,316–143,577,971); dup18p11.32p11.21
(Chr18:14,316–14,773,575); and dupXq22.3q27.2 (Chrx:106,283,188–140,340,737). The sum-
mary of CMA and clinical findings from the three patients with chromosomal duplications
can be seen in Supplementary S1 and Table 1, respectively.
3.2. DSi Proteins Tend to Have High Values of Betweenness
The human interactome provided a network-based framework to investigate protein-
protein interactions between DSi-proteins (Figure 1a). The extraction of protein-coding
genes from the duplicated regions and their first neighbor resulted in a DSi composed of
3016 nodes/proteins and 4330 links/interactions (Figure 1b). DSi included 89 proteins
from duplicated regions and 65 ID-genes. Four DSi-proteins (LAMA1, STAG2, NKAP,
and ALG13) were also found among the ID-genes list [35].
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Table 1. Summary of the CMA and clinical findings from the 3 patient with chromosomal duplications.
Patient 1 2 3
Sex F M F
Age (years) * 8 12 7











ID; speech delay; anxiety;
learning difficulty;
psychomotor agitation
ID; NPMDD; short stature;
clinodactyly;
blepharophimosis
ID: Intellectual disability; NPMDD: neuropsychomotor development delay. * age in years at the time of the CMA investigation.
Figure 1. Cytogenetic to the interactome. (a) left: duplicated regions mapped by CMA in the patients; right: curated
human interactome composed of 13,460 proteins and 141,296 interactions. In the network, proteins are nodes connected
by interactions. (b) expanded duplication syndromes interactome (eDSi) with 3016 proteins and 4330 interactions. Blue
nodes are protein-coding genes from duplicate regions; grey nodes are ID-genes. Node border colors represent the origin of
duplication: dup 8q24.13q24.3 in yellow; dup 18p11.32p11.21 in green; dupXq22.3-q27 in grey. Node size is related to the
number of connections (degree). (c) Topological parameters with degree and betweenness distribution and values of (d)
average shortest path length and closeness for duplicated protein-coding genes in eDSi. Dashed lines in black indicate the
average of these parameters for human interactome.
The average centrality measures in the human interactome were: degree (31.85),
betweenness (0.00013), closeness (0.3249), and shortest path length (3.119). Degree centrality
defines the number of connections of a specific node in the network, and in the biological
context, nodes with a degree value > 100 links (hubs) may have multiple functions in
cellular networks [36]. Betweenness corresponds to the number of nonredundant shortest
paths that pass through a node of interest and may indicate the potential of a protein to
create a bridge for communication between distant nodes [37,38]. The average shortest
path length involves the summa of all shortest paths between nodes couples, divided by all
pairs of nodes in the network, and the closeness indicates how close a node is to all other
nodes in the network [39,40].
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Many DSi-proteins showed higher values of centrality, compared to the mean of the
human interactome, indicating topological relevance to specific DSi-proteins (Figure 1c).
In this sense, 14% of DSi-proteins were considered hubs, including MYC, a transcription
factor, and CUL4B, a central component of the ubiquitin-protein ligase complex, both
acting in several biological processes. Moreover, other hubs, such as RBMX, PTK2, AIFM1,
VAPA, and XIAP, are associated with ID [41–45].
Eighty percent of the DSi-proteins reached a betweenness centrality value higher than
the average of the human interactome (Figure 1c). VGLL1 (coactivator for the mammalian
TEFs), CDR1 (neuronal signal transduction protein), MC5R (melanocortin receptor coupled
to the transmembrane G protein), and WISP1 (a member of the WNT1 inducible signaling
pathway) showed high betweenness values. All of these proteins have significant roles in
signal transduction or coactivation of transcription factors [46–49]. Furthermore, CDR1 is a
putative neuronal protein identified in individuals with cerebellar degeneration [50].
Besides degree and betweenness, shortest path length and closeness were calculated.
VGLL1, CDR1, WISP1, and MC5R also emerged in the network with high closeness and
lower shortest path length values (Figure 1c). From a biological perspective, these nodes
can have a major impact on proteins that are close to the node or serve as the shortest path
among distant proteins in the network. About 22% of the proteins were identified with
values of closeness and shortest path length above the average of the interactome. The main
results of the topological characteristics of other DSi-proteins can be seen in Figure 1c,d.
3.3. Biological Processes Associated with Rare Duplications
We carried out enrichment analysis of the DSi-proteins to identify biological processes
with a possible role in ID. Six clusters were detected grouping the main bioprocesses
(Figure 2). Cluster 1 identified only proteins from dup18p11.32p11.21 with enriched biopro-
cesses related to chromosome segregation. DSi-proteins from 8q24.13q24.3, 18p11.32p11.21,
and Xq22.3q27.2 were found in clusters 2 and 6, associated with telomere maintenance,
DNA repair, epithelium developmental, and ion transport. Cell morphogenesis in clusters
3 and 4 was associated with proteins from duplicated regions on chromosomes 8, 18, and
X. Cluster 5 is the only one to encompass proteins from the three duplicated regions, with
enrichment for microtubule cytoskeleton organization, negative regulation of cell cycle, and
neurogenesis. Cell pathways involving the ID pathophysiology can encompass changes in
the cytoskeleton dynamics, neurogenesis, and morphology during synaptic plasticity or
neuronal development [11,51].
Figure 2. Functional cluster detection in eDSi. Node border colors represent the origin of duplication:
dup 8q24.13q24.3 in yellow; dup 18p11.32p11.21 in green; dupXq22.3-q27 in grey. Small nodes in
light grey represent ID-genes.
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In addition, plasma membrane-bounded cell projection was enriched in the three dupli-
cated regions. This process involves the formation of a prolongation bounded by the plasma
membrane, such as an axon. Projection defects were reported in an ID mouse model [52].
Moreover, neuronal development and nuclear chromosome segregation were identified
in functional enrichment analysis of ID-genes and DSi-genes from dupXq22.3q27.2 and
dup18p11.32p11.21. The complete results are provided in Supplementary Table S3.
3.4. DSi-Genes Are Widely Expressed in the CNS
ID is caused by perturbations in the significant biological functions that impact cellular
networks present in different regions of the CNS. We identified the influence of each of
the 44 prioritized genes (Supplementary Table S5) in different tissues and found that these
genes are mainly expressed in the CNS when compared with other tissues in humans
(Figure 3) [14,16,53].
Figure 3. Expression of the 44 prioritized genes in ten different tissues. The average confidence value
is shown for each tissue.
Therefore, we extracted expression data from multiple CNS regions to better under-
stand the influence of each gene on this tissue (Figure 4). Many genes located at Xq22.3q27.2
are widely expressed in the CNS and were previously associated with syndromic/non-
syndromic X-linked ID, such as ALG13, PAK3, THOC2, GRIA3, STAG2, OCRL1, AIFM1,
PHF6, RMBX, SOX3, LAMP2, CUL4B, and UBE2A [54,55]. Moreover, patients with dupli-
cated regions that encompass the X-linked genes SOX3, STAG2, AIFM1, GRIA3, PAK3, and
OCRL exhibit ID [22–26,56–58]. Moreover, six genes from the duplicated region 18p11.32-
p11.21 are highly expressed in several regions of the CNS, from which three of them (LAMA1,
MYOM1, and TGIF1) were duplicated in individuals with ID [18–20]. Furthermore, patients
with duplication of 8q24.13q24.3 region involving the KCNQ3, PTK2, ASAP1, and NDRG1
genes, which are widely expressed in CNS, presented ID [14,16,53].
3.5. Candidate Proteins from Different Chromosome Rearrangements Interact with Each Other in
the CNS Network
To analyze the relevance of candidate proteins according to tissue specificity, we
constructed a network with interactions from the CNS, in an attempt to identify clues about
the likely contribution of each protein in the development of ID. The CNS network includes
32 nodes connected by 210 interactions, from which 18 are DSi proteins (Figure 5a). The most
connected proteins are PTK2 (19), STAG2 (16), and TGIF1 (16). Interestingly, ID-genes WAC,
QKI, and PPP1R12A emerge as interacting factors on the network by automatic addition of
the database. It is worth mentioning that many links in the tissue-specific network result
Genes 2021, 12, 632 7 of 15
from gene co-expression studies in the context of neurological conditions, such as recessive
X-linked dystonia-parkinsonism, Rett syndrome, and Huntington’s disease.
Figure 4. Heat map of expression of the 44 prioritized genes in CNS. Confidence value is calculated
between 0–1.
Figure 5. Tissue-specific gene network analysis. (a) functional network from CNS. Blue nodes are
protein-coding genes from duplicate regions; grey nodes are ID-genes; black nodes were added by
the database. Node border colors represent the origin of duplication: dup 8q24.13q24.3 in yellow;
dup 18p11.32p11.21 in green; dupXq22.3-q27 in grey. Score values are shown proportionally by the
thickness and intensity color of the edges. (b) heat map of genes from tissue-specific gene network
with the most significant biological processes. (c) Scheme depicting the main pathways and molecules
involved in axon guidance.
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The functional enrichment analysis identified several pathways associated with axon
guidance (Figure 5b). The genes directly involved with this biological process include PTK2
and KCNK3 (dup 8q24.13q24.3), LAMA1 (dup 18p11.32p11.21), and PAK3, DCX, SOX3, and
OCRL (dupXq22.3-q27). As mentioned above, all these genes have already been identified
in duplicated regions in individuals with ID. Moreover, LAMA1 was also present in our ID-
list which used the candidate genes prioritization. Pathways related to functions necessary
to axon guidance that encompasses these genes, include actin cytoskeleton regulation
(p = 0.0060), L1CAM interactions (p < 0.0001), EPH-ephrin signaling (p = 0.0107), signaling
by Rho GTPases (p = 0.0029) and MET cell motility promotion (p = 0.0003). However,
other fundamental pathways in the axon guidance context can be seen in Figure 5b. The
PPP1R12A gene, added to the database, is the only one not belonging to the duplicated
region that appears in the ID-genes list and is involved in axon guidance.
Taken together, these results indicate that genes from different duplicated regions may
be related to each other and other genes previously associated with ID localized in cellular
networks in the nervous tissue and involved in neurodevelopment processes (Figure 5c).
3.6. Candidate Genes Are Associated with the ID
Similar pathways are disrupted in ID and in other neurological diseases due to the
functional relationships of genes located in the same module in the human interactome.
Therefore, to identify DSi-genes implicated in other neurological diseases, and help to
confirm our results, we generated a gene–disease association network (Figure 6).
Figure 6. Gene–disease associations network. Duplicated genes (circular nodes) and disease of CNS
(rectangular nodes). The size of the circle nodes corresponds to the number of diseases associated.
Blue nodes are protein-coding genes from duplicate regions; orange nodes are candidate genes. Node
border colors represent the origin of duplication: dup 8q24.13q24.3 in yellow; dup 18p11.32p11.21 in
green; dupXq22.3-q27 in grey. Scores values are shown proportionally by the thickness and intensity
color of the edges. Orange edges show interactions of candidate genes.
The most common diseases or phenotypes found on the network were autism spec-
trum disorder, peripheral CNS disease, and ID with 43, 17, and 15 associated genes,
respectively. Maximum scores between disease and genes were seen in brain disease, holo-
prosencephaly, syndromic/non-syndromic ID, and syndromic/non-syndromic X-linked
ID. The genes with the highest number of connections with other diseases were PAK3,
GRIA3, and ADGRB1 associated with eight, six, and six neurological diseases, respectively.
As expected, these genes were the most expressed in the CNS tissue (Figure 3). Previous
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data support the known relationships of many genes on the network with neurological dis-
eases, especially located in Xq22.3-q27.2 [55]. Moreover, the candidate genes PAK3, OCRL,
DCX, PTK2, KCNQ3, SOX3, and LAMA1 were associated with autism, brain disease, Dent
disease, and other conditions that present ID as a hallmark, corroborating our findings
(Figure 6).
4. Discussion
Genomic disorders caused by duplications of chromosome segments confer potential
risk of global developmental delay and ID, impacting the IQ, and educational achievement of
individuals [59–61]. The imbalance in gene dosage caused by chromosomal duplications can
destabilize several genes by spreading through interactions in cellular subnetworks during
neurodevelopment. Moreover, the chromosome rearrangements identified in our patients
are rare, with few cases reported so far. These duplicated regions have been reported as
pathogenic and ID is a recurrent clinical finding in the affected individuals [16,21,26]. There-
fore, we used network analysis in an attempt to identify the potential sharing of biological
processes and genes responsible for the pathophysiology of ID in rare duplications. We found
seven candidate genes: PTK2 and KCNK3 (dup 8q24.13q24.3), LAMA1 (dup 18p11.32p11.21),
and PAK3, DCX, SOX3, and OCRL from dupXq22.3q27, all duplicated in individuals with
ID [15,16,19,23,25,55–57,61]. Furthermore, all candidate genes identified have been reported
in duplicated regions of several ID patients in the web-based database—DECIPHER.
PTK2, protein tyrosine kinase 2, emerged with high degree and betweenness values
(hub-bottleneck) through topological analysis in the eDSi (Figure 1c). This result correctly
reflects the many biological functions performed by PTK2 that involve the regulation of
migration, adhesion, protrusion, and proliferation of the cell. Besides that, PTK2 pro-
motes axon growth and guidance and synapse formation during CNS development [62–65].
Therefore, changes in PTK2 expression can impair brain development and lead to mental
conditions [66]. Our topological analysis supports the identification of candidate disease
genes that tend to be more central to the network, and not in peripheral regions as we
expected [67,68]. Moreover, we identified many proteins from duplicated regions with high
betweenness values considered bottlenecks, essential nodes in the information flow between
distant proteins in cellular networks [38], indicating a potential impact in pathophysiology,
when dysregulated.
We identified significant expression of duplicated genes in the CNS conversely to other
tissues (Figure 3). Moreover, candidate genes present remarkable expression in regions of CNS
associated with ID (Figure 4), such as the cortical region and the cerebellum [10]. Candidate
genes from different chromosomes interact with each other in the tissue-specific network,
demonstrating functional relationships among these genes in the CNS. For instance, PTK2
(chr:8) interacts directly with OCRL (inositol polyphosphate-5-phosphatase—chr:X), DCX
(doublecortin—chr:X) with LAMA1 (laminin subunit α 1—chr:18), or yet, KCNQ3 (potassium
voltage-gated channel subfamily Q member 3—chr:8) and LAMA1 are connected to each
other by the neurotrophic tyrosine receptor kinase (NTRK3) (Figure 5a). Furthermore, OCRL
and PTK2 interacts directly with WAC, QKI, and PPP1R12A, genes previously associated with
ID [69–72]. In the case of PPP1R12A, its loss-of-function causes holoprosencephaly and ID
in individuals with stop gain variants and deletions/duplications, resulting in a frameshift
effect [72]. PPP1R12A protein is present in pathways, such as RHO actin cytoskeleton regu-
lation, ROCKs activation by GTPases, dendritic spine morphogenesis, and stabilization, all
bioprocesses directly or indirectly involved with axon guidance mechanisms.
Axon guidance was the most enriched term in the tissue-specific network, besides the
identification of various signaling pathways directly or indirectly involved in this biological
process (Figure 5b). The axon guidance process plays an essential function in neuronal wiring
in the developing spinal cord, where it is responsible for extending axons and reaching their
targets to form synaptic junctions. These mechanisms allow the connection between the
central and peripheral nervous system during neurodevelopment, through extracellular and
transmembrane molecules and their cell surface receptors [73–75]. The main axon guidance
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pathways and mechanisms involving our candidate genes were schematized in Figure 5c.
The disruption or disintegration of neural circuit formation during CNS development affects
cognitive function and can result in mental conditions such as ID [76–78]. The current model
of the axon orientation mechanism reveals that the expression of guidance receptors occurs
in the growth cone to indicate their targets and allow migration by controlling attractive and
repulsive forces containing many guidance molecules present in their environment [75,77].
Therefore, the model of neural circuit formation supports the idea that changes in gene
dosage caused by chromosomal duplications may impair the balance of this mechanism
during the CNS development [79], where the gain or loss-of-function can impair the tight
regulation of gene sets and cause disturbances in neighbor proteins in networks. However,
expression data from patients with these chromosomal duplications should be used to
confirm this model.
We observed interactions in the gene-disease association network between neurologi-
cal conditions with ID and DSi-genes of three different chromosomes (Figure 6). These data
suggest that duplicated regions could generate perturbations and propagate through mod-
ules in the interactome associated with many diseases linked to the CNS. For instance, the
partial duplication of the gene that encodes the neuronal development transcription factor
SOX3 can cause impairment in pituitary development and cognitive functions [80]. PAK3
is expressed in the brain, playing a role in the control of cytoskeleton regulation, cell migra-
tion, axonal guidance, and synaptic plasticity, while its deregulation causes neurological
abnormalities, such as ID [81,82]. PAK3 pathogenic variants in affected males were associ-
ated with spatial cognitive abilities, defects in attention, and speech difficulties [83,84], and
a hemizygous missense variant in this gene was found in two male siblings with ID [85].
OCRL regulates the traffic in the endosomal machinery and its depletion affects the recy-
cling of various classes of receptors [86]. Dent disease patients with pathogenic variants in
the OCRL can present mental impairment [87,88]. Already, DCX plays a crucial role in the
CNS, enhancing the axonal outgrowth in postnatal cortical neurons [89]. Variants in DCX
result in X-linked lissencephaly in males, and its overexpression leads to destabilization of
microtubules and inhibition of neurite outgrowth [90]. Beyond the PTK2 gene (a duplicated
region on chromosome 8), KCNQ3 encodes a protein with functions in the regulation of
neuronal excitability and plasticity [91,92]. Pathogenic variants in this gene were identified
in patients with early-onset epilepsy and neurocognitive deficits [93]. Moreover, a gain of
function variants in KCNQ3 causes neurodevelopmental delay and autistic features [94].
Lastly, LAMA1 (duplicated region on chromosome 18), laminin involved in cell adhesion
and axon outgrowth during embryonic development is associated with cerebellar dysplasia
and ID in individuals with homozygous variants [95–98].
The phenotype in these conditions is not only the result of deficient protein, but also
perturbations that spread in the cellular networks. Therefore, the network-based analysis,
regardless of the origin of the pathogenesis of chromosomal duplications (epigenetic
alteration, gain of function, effect of position, change of transcription factor sites, or
deregulation of miRNAs), can help to predict the consequence of these mechanisms by
analyzing functional protein relationships and their interactions in a network [99,100].
5. Conclusions
We found functional relationships among genes from three different duplicated chro-
mosomal regions, reflecting interactions of protein-coding genes and their involvement
in common cellular subnetworks. Furthermore, the sharing of common significant bio-
logical processes associated with ID has been demonstrated between proteins from the
different chromosomal regions. According to our results, we indicate potential molecules
and signaling pathways responsible for neuronal wiring that can be deregulated during
neurodevelopment and cause ID. Further analysis of gene expression would be necessary to
generate experimental data for these conditions in order to show more evidence regarding
the association between gene expression and ID.
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Walczak, A.; Kędra, A.; et al. Spondyloepimetaphyseal Dysplasia with Neurodegeneration Associated with AIFM1 Mutation—A
Novel Phenotype of the Mitochondrial Disease. Clin. Genet. 2017, 91, 30–37. [CrossRef] [PubMed]
45. Riazuddin, S.; Hussain, M.; Razzaq, A.; Iqbal, Z.; Shahzad, M.; Polla, D.L.; Song, Y.; Van Beusekom, E.; Khan, A.A.;
Tomas-Roca, L.; et al. Exome Sequencing of Pakistani Consanguineous Families Identifies 30 Novel Candidate Genes for Re-
cessive Intellectual Disability. Mol. Psychiatry 2017, 22, 1604–1614. [CrossRef]
46. Pennica, D.; Swanson, T.A.; Welsh, J.W.; Roy, M.A.; Lawrence, D.A.; Lee, J.; Brush, J.; Taneyhill, L.A.; Deuel, B.; Lew, M.; et al.
WISP Genes Are Members of the Connective Tissue Growth Factor Family That Are Up-Regulated in Wnt-1-Transformed Cells
and Aberrantly Expressed in Human Colon Tumors. Proc. Natl. Acad. Sci. USA 1998, 95, 14717–14722. [CrossRef]
47. Hatta, N.; Dixon, C.; Ray, A.J.; Phillips, S.R.; Cunliffe, W.J.; Dale, M.; Todd, C.; Meggit, S.; Birch-Machin, M.A.; Rees, J.L.
Expression, Candidate Gene, and Population Studies of the Melanocortin 5 Receptor. J. Investig. Dermatol. 2001, 116, 564–570.
[CrossRef]
48. Mahoney, W.M.; Hong, J.H.; Yaffe, M.B.; Farrance, I.K.G. The Transcriptional Co-Activator TAZ Interacts Differentially with
Transcriptional Enhancer Factor-1 (TEF-1) Family Members. Biochem. J. 2005, 388, 217–225. [CrossRef]
49. Bosco, P.; Spada, R.; Caniglia, S.; Salluzzo, M.G.; Salemi, M. Cerebellar Degeneration-Related Autoantigen 1 (CDR1) Gene
Expression in Alzheimer’s Disease. Neurol. Sci. 2014, 35, 1613–1614. [CrossRef]
50. Dropchot, E.J.; Chen, Y.; Posnert, J.B.; Old, L.J. Cloning of a Brain Protein Identified by Autoantibodies from a Patient with
Paraneoplastic Cerebellar Degeneration. Proc. Natl. Acad. Sci. USA 1987, 84, 4552–4556. [CrossRef]
51. Cappello, S. Small Rho-GTPases and Cortical Malformations: Fine-Tuning the Cytoskeleton Stability. Small GTPases 2013, 4, 51–56.
[CrossRef]
52. Chen, L.; Liao, G.; Waclaw, R.R.; Burns, K.A.; Linquist, D.; Campbell, K.; Zheng, Y.; Kuan, C.Y. Rac1 Controls the Formation
of Midline Commissures and the Competency of Tangential Migration in Ventral Telencephalic Neurons. J. Neurosci. 2007, 27,
3884–3893. [CrossRef]
53. Bruni, V.; Roppa, K.; Scionti, F.; Apa, R.; Sestito, S.; Di Martino, M.T.; Pensabene, L.; Concolino, D. A 46,XY Female with a
9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. Cytogenet. Genome Res. 2019.
[CrossRef]
54. Neri, G.; Schwartz, C.E.; Lubs, H.A.; Stevenson, R.E. X-Linked Intellectual Disability Update 2017. Am. J. Med. Genet. Part A 2018,
176, 1375–1388. [CrossRef]
55. Tejada, M.I.; Ibarluzea, N. Non-Syndromic X Linked Intellectual Disability: Current Knowledge in Light of the Recent Advances
in Molecular and Functional Studies. Clin. Genet. 2020, 97, 677–687. [CrossRef]
56. Di Benedetto, D.; Musumeci, S.A.; Avola, E.; Alberti, A.; Buono, S.; Scuderi, C.; Grillo, L.; Galesi, O.; Spalletta, A.; Giudice, M.L.; et al.
Definition of Minimal Duplicated Region Encompassing the XIAP and STAG2 Genes in the Xq25 Microduplication Syndrome. Am. J.
Med. Genet. Part A 2014, 164, 1923–1930. [CrossRef]
57. Arya, V.B.; Chawla, G.; Nambisan, A.K.R.; Muhi-Iddin, N.; Vamvakiti, E.; Ajzensztejn, M.; Hulse, T.; Ferreira Pinto, C.; Lahiri,
N.; Bint, S.; et al. Xq27.1 Duplication Encompassing SOX3: Variable Phenotype and Smallest Duplication Associated with
Hypopituitarism to Date-A Large Case Series of Unrelated Patients and a Literature Review. Horm. Res. Paediatr. 2019. [CrossRef]
58. Jin, Z.; Yu, L.; Geng, J.; Wang, J.; Jin, X.; Huang, H. A Novel 47.2Mb Duplication on Chromosomal Bands Xq21.1-25 Associated
with Mental Retardation. Gene 2015, 567, 98–102. [CrossRef]
59. Nishi, A.; Hiroi, N. Genetic Mechanisms Emerging from Mouse Models of CNV-Associated Neuropsychiatric Disorders; Elsevier Inc.:
Amsterdam, The Netherlands, 2016; ISBN 9780128018774.
60. Bass, N.; Skuse, D. Genetic Testing in Children and Adolescents with Intellectual Disability. Curr. Opin. Psychiatry 2018, 31,
490–495. [CrossRef]
61. Huguet, G.; Schramm, C.; Douard, E.; Jiang, L.; Labbe, A.; Tihy, F.; Mathonnet, G.; Nizard, S.; Lemyre, E.; Mathieu, A.; et al.
Measuring and Estimating the Effect Sizes of Copy Number Variants on General Intelligence in Community-Based Samples.
JAMA Psychiatry 2018, 75, 447–457. [CrossRef]
62. Liu, G.; Beggs, H.; Jürgensen, C.; Park, H.T.; Tang, H.; Gorski, J.; Jones, K.R.; Reichardt, L.F.; Wu, J.; Rao, Y. Netrin Requires Focal
Adhesion Kinase and Src Family Kinases for Axon Outgrowth and Attraction. Nat. Neurosci. 2004, 7, 1222–1232. [CrossRef]
63. Liu, T.J.; LaFortune, T.; Honda, T.; Ohmori, O.; Hatakeyama, S.; Meyer, T.; Jackson, D.; de Groot, J.; Yung, W.K.A. Inhibition of
Both Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Kinase Suppresses Glioma Proliferation in Vitro and
in Vivo. Mol. Cancer Ther. 2007, 6, 1357–1367. [CrossRef] [PubMed]
64. Lim, S.T.; Chen, X.L.; Lim, Y.; Hanson, D.A.; Vo, T.T.; Howerton, K.; Larocque, N.; Fisher, S.J.; Schlaepfer, D.D.; Ilic, D. Nuclear FAK
Promotes Cell Proliferation and Survival through FERM-Enhanced P53 Degradation. Mol. Cell 2008, 29, 9–22. [CrossRef] [PubMed]
65. Schaller, M.D. Cellular Functions of FAK Kinases: Insight into Molecular Mechanisms and Novel Functions. J. Cell Sci. 2010, 123,
1007–1013. [CrossRef] [PubMed]
Genes 2021, 12, 632 14 of 15
66. Xu, D.; Shen, W.; Guo, R.; Xue, Y.; Peng, W.; Sima, J.; Yang, J.; Sharov, A.; Srikantan, S.; Yang, J.; et al. Top3β Is an RNA
Topoisomerase That Works with Fragile X Syndrome Protein to Promote Synapse Formation. Nat. Neurosci. 2013, 16, 1238–1247.
[CrossRef]
67. Goh, K.I.; Cusick, M.E.; Valle, D.; Childs, B.; Vidal, M.; Barabási, A.L. The Human Disease Network. Proc. Natl. Acad. Sci. USA
2007, 104, 8685–8690. [CrossRef]
68. Zotenko, E.; Mestre, J.; O’Leary, D.P.; Przytycka, T.M. Why Do Hubs in the Yeast Protein Interaction Network Tend to Be Essential:
Reexamining the Connection between the Network Topology and Essentiality. PLoS Comput. Biol. 2008, 4, e1000140. [CrossRef]
69. Backx, L.; Marcelis, C.; Devriendt, K.; Vermeesch, J.; Van Esch, H.; Fryns, J.-P. Haploinsufficiency of the gene Quaking (QKI) is
associated with the 6q terminal deletion syndrome. Am. J. Med. Genet. Part A 2010, 152A, 319–326. [CrossRef]
70. Lugtenberg, D.; Reijnders, M.R.F.; Fenckova, M.; Bijlsma, E.K.; Bernier, R.; Van Bon, B.W.M.; Smeets, E.; Silfhout, A.T.V.-V.; Bosch,
D.; Eichler, E.E.; et al. De novo loss-of-function mutations in WAC cause a recognizable intellectual disability syndrome and
learning deficits in Drosophila. Eur. J. Hum. Genet. 2016, 24, 1145–1153. [CrossRef]
71. Uehara, T.; Ishige, T.; Hattori, S.; Yoshihashi, H.; Funato, M.; Yamaguchi, Y.; Takenouchi, T.; Kosaki, K. Three patients with
DeSanto-Shinawi syndrome: Further phenotypic delineation. Am. J. Med. Genet. Part A 2018, 176, 1335–1340. [CrossRef]
72. Hughes, J.J.; Alkhunaizi, E.; Kruszka, P.; Pyle, L.C.; Grange, D.K.; Berger, S.I.; Payne, K.K.; Masser-Frye, D.; Hu, T.; Christie,
M.R.; et al. Loss-of-Function Variants in PPP1R12A: From Isolated Sex Reversal to Holoprosencephaly Spectrum and Urogenital
Malformations. Am. J. Hum. Genet. 2020, 106, 121–128. [CrossRef]
73. Russell, S.A.; Bashaw, G.J. Axon guidance pathways and the control of gene expression. Dev. Dyn. 2017, 247, 571–580. [CrossRef]
74. Suter, T.A.C.S.; Jaworski, A. Cell migration and axon guidance at the border between central and peripheral nervous system.
Science 2019, 365, eaaw8231. [CrossRef]
75. Chédotal, A. Roles of axon guidance molecules in neuronal wiring in the developing spinal cord. Nat. Rev. Neurosci. 2019, 20,
380–396. [CrossRef]
76. Engle, E.C. Human Genetic Disorders of Axon Guidance. Cold Spring Harb. Perspect. Biol. 2010, 2, a001784. [CrossRef]
77. Stoeckli, E.T. Understanding axon guidance: Are we nearly there yet? Development 2018, 145, dev151415. [CrossRef]
78. Takabatake, M.; Goshima, Y.; Sasaki, Y. Semaphorin-3A Promotes Degradation of Fragile X Mental Retardation Protein in Growth
Cones via the Ubiquitin-Proteasome Pathway. Front. Neural Circuits 2020, 14, 1–9. [CrossRef]
79. O’Donnell, M.; Chance, R.K.; Bashaw, G.J. Axon Growth and Guidance: Receptor Regulation and Signal Transduction. Annu. Rev.
Neurosci. 2009, 32, 383–412. [CrossRef]
80. Jourdy, Y.; Chatron, N.; Carage, M.L.; Fretigny, M.; Meunier, S.; Zawadzki, C.; Gay, V.; Negrier, C.; Sanlaville, D.; Vinciguerra, C.
Study of six patients with completeF9deletion characterized by cytogenetic microarray: Role of theSOX3gene in intellectual
disability. J. Thromb. Haemost. 2016, 14, 1988–1993. [CrossRef]
81. Kreis, P.; Barnier, J.-V. PAK signalling in neuronal physiology. Cell. Signal. 2009, 21, 384–393. [CrossRef]
82. Parker, N.H.; Donninger, H.; Birrer, M.J.; Leaner, V.D. p21-Activated Kinase 3 (PAK3) Is an AP-1 Regulated Gene Contributing to
Actin Organisation and Migration of Transformed Fibroblasts. PLoS ONE 2013, 8, e66892. [CrossRef]
83. Peippo, M.; Koivisto, A.M.; Särkämö, T.; Sipponen, M.; Von Koskull, H.; Ylisaukko-Oja, T.; Rehnström, K.; Froyen, G.; Ignatius, J.;
Järvelä, I. PAK3 related mental disability: Further characterization of the phenotype. Am. J. Med. Genet. Part A 2007, 143A,
2406–2416. [CrossRef]
84. Rejeb, I.; Saillour, Y.; Castelnau, L.; Julien, C.; Bienvenu, T.; Taga, P.; Chaabouni, H.; Chelly, J.; Jemaa, L.B.; Bahi-Buisson, N.
A novel splice mutation in PAK3 gene underlying mental retardation with neuropsychiatric features. Eur. J. Hum. Genet. 2008, 16,
1358–1363. [CrossRef]
85. Qian, Y.; Wu, B.; Lu, Y.; Zhou, W.; Wang, S.; Wang, H. Novel PAK3 gene missense variant associated with two Chinese siblings
with intellectual disability: A case report. BMC Med. Genet. 2020, 21, 31. [CrossRef]
86. Vicinanza, M.; Di Campli, A.; Polishchuk, E.; Santoro, M.; Di Tullio, G.; Godi, A.; Levtchenko, E.; De Leo, M.G.; Polishchuk, R.;
Sandoval, L.; et al. OCRL Controls Trafficking through Early Endosomes via PtdIns4,5P 2-Dependent Regulation of Endosomal
Actin. EMBO J. 2011, 30, 4970–4985. [CrossRef] [PubMed]
87. Hoopes, R.R.; Shrimpton, A.E.; Knohl, S.J.; Hueber, P.; Hoppe, B.; Matyus, J.; Simckes, A.; Tasic, V.; Toenshoff, B.; Suchy, S.F.; et al.
Dent Disease with Mutations in OCRL1. Am. J. Hum. Genet. 2005, 76, 260–267. [CrossRef] [PubMed]
88. Böckenhauer, D.; Bökenkamp, A.; Nuutinen, M.; Unwin, R.; Van’t Hoff, W.; Sirimanna, T.; Vrljicak, K.; Ludwig, M. Novel OCRL
Mutations in Patients with Dent-2 Disease. J. Pediatr. Genet. 2012, 1, 15–23. [CrossRef] [PubMed]
89. Blackmore, M.G.; Moore, D.L.; Smith, R.P.; Goldberg, J.L.; Bixby, J.L.; Lemmon, V.P. High Content Screening of Cortical Neurons
Identifies Novel Regulators of Axon Growth. Mol. Cell. Neurosci. 2010, 44, 43–54. [CrossRef]
90. Shahsavani, M.; Pronk, R.J.; Falk, R.; Lam, M.; Moslem, M.; Linker, S.B.; Salma, J.; Day, K.; Schuster, J.; Anderlid, B.M.; et al. An in
Vitro Model of Lissencephaly: Expanding the Role of DCX during Neurogenesis. Mol. Psychiatry 2018, 23, 1674–1684. [CrossRef]
91. Robbins, J. KCNQ Potassium Channels: Physiology, Pathophysiology, and Pharmacology. Pharmacol. Ther. 2001, 90, 1–19. [CrossRef]
92. Surti, T.S.; Huang, L.; Jan, Y.N.; Jan, L.Y.; Cooper, E.C. Identification by Mass Spectrometry and Functional Characterization of
Two Phosphorylation Sites of KCNQ2/KCNQ3 Channels. Proc. Natl. Acad. Sci. USA 2005, 102, 17828–17833. [CrossRef]
93. Miceli, F.; Striano, P.; Soldovieri, M.V.; Fontana, A.; Nardello, R.; Robbiano, A.; Bellini, G.; Elia, M.; Zara, F.; Taglialatela, M.; et al.
A Novel KCNQ3 Mutation in Familial Epilepsy with Focal Seizures and Intellectual Disability. Epilepsia 2015, 56, e15–e20. [CrossRef]
Genes 2021, 12, 632 15 of 15
94. Sands, T.T.; Miceli, F.; Lesca, G.; Beck, A.E.; Sadleir, L.G.; Arrington, D.K.; Schönewolf-Greulich, B.; Moutton, S.; Lauritano, A.;
Nappi, P.; et al. Autism and Developmental Disability Caused by KCNQ3 Gain-of-Function Variants. Ann. Neurol. 2019, 86,
181–192. [CrossRef]
95. Gu, Y.C.; Kortesmaa, J.; Tryggvason, K.; Persson, J.; Ekblom, P.; Jacobsen, S.E.; Ekblom, M. Laminin Isoform-Specific Promotion of
Adhesion and Migration of Human Bone Marrow Progenitor Cells. Blood 2003, 101, 877–885. [CrossRef]
96. Najmabadi, H.; Hu, H.; Garshasbi, M.; Zemojtel, T.; Abedini, S.S.; Chen, W.; Hosseini, M.; Behjati, F.; Haas, S.; Jamali, P.; et al.
Deep Sequencing Reveals 50 Novel Genes for Recessive Cognitive Disorders. Nature 2011, 478, 57–63. [CrossRef]
97. Aldinger, K.A.; Mosca, S.J.; Tétreault, M.; Dempsey, J.C.; Ishak, G.E.; Hartley, T.; Phelps, I.G.; Lamont, R.E.; O’Day, D.R.;
Basel, D.; et al. Mutations in LAMA1 Cause Cerebellar Dysplasia and Cysts with and without Retinal Dystrophy. Am. J. Hum.
Genet. 2014, 95, 227–234. [CrossRef]
98. Micalizzi, A.; Poretti, A.; Romani, M.; Ginevrino, M.; Mazza, T.; Aiello, C.; Zanni, G.; Baumgartner, B.; Borgatti, R.; Brockmann, K.; et al.
Clinical, Neuroradiological and Molecular Characterization of Cerebellar Dysplasia with Cysts (Poretti-Boltshauser Syndrome). Eur.
J. Hum. Genet. 2016, 24, 1262–1267. [CrossRef]
99. Corrêa, T.; Poswar, F.; Feltes, B.C.; Riegel, M. Candidate Genes Associated With Neurological Findings in a Patient With Trisomy
4p16.3 and Monosomy 5p15.2. Front. Genet. 2020, 11, 1–8. [CrossRef]
100. Corrêa, T.; Feltes, B.C.; Schinzel, A.; Riegel, M. Network-Based Analysis Using Chromosomal Microdeletion Syndromes as a
Model. Am. J. Med. Genet. Part C Semin. Med. Genet. 2021, 1–12. [CrossRef]
